RP-3500
ATR kinase inhibitor phase I/IIa candidate for advanced solid tumors from lipid-kinase inhibitor scaffold Molecular Cancer Therapeutics Repare Therapeutics, Saint-Laurent, CAN
Molecules of the Month - December 2021
Molecules of the Month
- MRTX1133
- CC-90001
- HTT-D3
- ulotaront
- velsecorat
- “compound 22”
- “compound 43b”
- RP-3500
- HR011303
- “compound 54c”
- “compound 17a”
- “compound 3”
- “compound 24”
- “compound 25”